Effect of various agonists on nitric oxide generation by human polymorphonuclear leukocytes

International Journal of Clinical and Laboratory Research

Volumn 28, Issue 2, 1998, Pages 104-109

  Stolarek, R ^a   Kula, P ^a   Kurmanowska, Z ^a   Nowak, D ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

N Formyl methionyl leucyl phenylalanine; Nitric oxide; Phorbol myristate acetate; Polymorphonuclear leukocytes

Indexed keywords

CONCANAVALIN A; ENZYME INHIBITOR; FORMYLMETHIONYLLEUCYLPHENYLALANINE; N(G) METHYLARGININE; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHORBOL 13 ACETATE 12 MYRISTATE; THROMBOCYTE ACTIVATING FACTOR;

ARTICLE; BIOSYNTHESIS; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; METABOLISM; NEUTROPHIL;

CONCANAVALIN A; ENZYME INHIBITORS; HUMANS; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHILS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROARGININE; OMEGA-N-METHYLARGININE; PLATELET ACTIVATING FACTOR; TETRADECANOYLPHORBOL ACETATE;

EID: 0031875930     PISSN: 09405437     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005990050028     Document Type: Article

References (24)

1. Yan L, Vandivier RW, Suffredini AF, Danner RL. Human polymorphonuclear leukocytes lack detectable nitric oxide synthase activity. J Immunol 1994[ 4:1825.
2. Miles AM, Owens MW, Milligan S, Johnson GG, Fields JZ, Ing TS, Kattapalli V, Keshavarzian A, Grisham MB. Nitric oxide synthase in circulating vs extravasated polymorphonuclear leukocytes. J Leukoc Biol 1995, 58:616.
3. Nathan C, Xie Q. Nitric oxide synthases: roles, tolls and controls. Cell 1994; 78:915.
4. Rimele TJ, Strum RJ, Adams LM, Henry DE, Heaslip RJ, Weichman BM, Grimes D. Interaction of neutrophils with smooth muscle: identification of a neutrophil-derived relaxing factor. J Pharmacol Exp Ther 1988; 245:102.
5. McCall TB, Boughton-Smith NK, Palmer RMJ, Whittle BJR, Moncada S. Synthesis of nitric oxide from L-arginine by neutrophils. Biochem J 1989; 261:293.
6. Gaston B, Drazen JM, Loscalzo J, Stamler JS. The biology of nitrogen oxides in the airways. Am J Respir Crit Care Med 1994; 149:538.
7. Huang PL, Fishman MC. Genetic analysis of nitric oxide synthase isoforms: targeted mutation in mice. J Mol Med 1996; 74:415.
8. Bastian NR, Hibbs JB. Assembly and regulation of NADPH oxidase and nitric oxide synthase. Curr Opin Immunol 1994; 6:131.
9. Pheng LH, Francoeur C, Denis M The involvement of nitric oxide in mouse model of adult respiratory distress syndrome. Inflammation 1995; 5:599.
10. Evans T, Carpenter A, Kinderman H, Cohen J. Evidence of increased nitric oxide production in patients with the sepsis syndrome Circ Shock 1993; 41:77.
11. Nava E, Palmer RMJ, Moncada S. Inhibition of nitric oxide synthesis in septic shock: how much is beneficial? Lancet 1991; 338:1555.
12. Nakazawa H, Fukuyama N. Is free radical generation an important component of ischemia/reperfusion injury? Redox Rep 1995, 1:177.
13. Evans TJ, Buttery LD, Carpenter A, Springall DR, Polak JM, Cohen J. Cytokine-treated human neutrophils contain inducible nitric oxide synthase that produces nitration of ingested bacteria. Proc Natl Acad Sci USA 1996; 93:9553.
14. Amin AR, Attur M, Vyas P, Leszczynska J, Levartovsky D, Rediske J, Clancy RM, Vora KA, Abramson SB. Expression of nitric oxide synthase in human peripheral blood mononuclear cells and neutrophils. J Inflamm 1996; 47:190.
15. Wallerath T, Gath I, Aulitzky WE, Pollock JS, Kleinert H, Forsterman U. Identification of the NO isoforms expressed in human neutrophil granulocytes, megakaryocytes and platelets. Thromb Haemost 1997; 77:163.
16. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 1968; 97 [Suppl]: 77
17. Archer S. Measurements of nitric oxide in biological models. FASEBJ 1993; 7:349.
18. Korchak HM, Vosshall LB, Zagon G, Ljubich P, Rich AM, Weissmann G. Activation of the neutrophil by calcium-mobilizing ligands. J Biol Chem 1988; 23:11090.
19. Nowak D, Antczak A, Bialasiewicz P, Piasecka G, Krol M, Pietras T Effect of ambroxol on cytosolic calcium rise in human polymorphonuclear leukocytes after stimulation with N-formyl-methionyl-leucyl-phenylalanine and concanavatin A. Int J Immunopharmacol 1994; 7:47
20. 2+], transients in human polymorphonuclear leukocytes. J Lipid Mediat Cell Signal 1996; 13:163.
21. Nowak D, Bialasiewicz P, Antczak A, Krol M, Piasecka G. Changes of intracellular free calcium concentration in human polymorphonuclear leukocytes after repeated stimulation with N-formyl-methionyl-leucyl-phenylalanine. Immunobiology 1995; 192:343.
22. Jesaitis AJ, Naemura JR, Painter RG, Schmitt M, Sklar LA, Cochrane CG. The fate of the N-formyl-chemotactic peptide receptor in stimulated human granulocytes: subcellular fractionation studies. J Cell Biochem 1982; 20:177.
23. Jesaitis AJ, Naemura JR, Painter RG, Schmitt M, Sklar LA, Cochrane CG. The fate of the N-formylated chemotactic peptide in stimulated human granulocytes: subcellular fractionation studies. J Biol Chem 1982; 258:1968.
24. Koshida H, Kotake Y. Nitric oxide does not contribute to superoxide-mediated sulfhydryl oxidation in human polymorphonuclear leukocytes. Life Sci 1994; 6:463.